ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
Align Technology (ALGN) reported Q3 2026 earnings of $2.80 per share, up 7.3% YoY, and revenues of $1.01B, up 1.9% YoY. Clear Aligner shipments increased 6.6% YoY. ALGN shares fell 0.7% post-earnings. The company lowered its 2026 revenue outlook, citing softer expectations for Systems and Services business. Q4 revenue guidance is $1.00-$1.02B, below consensus of $1.05B.
How this was made
The 30-second read
Why it matters
The earnings beat offers short‑term support, yet the reduced guidance introduces downside risk, especially for the Systems and Services segment.
Market read
Earnings and guidance update for a major dental‑tech company; impacts both the clear aligner market and broader dental equipment sector.
What to watch
The record number of doctors submitting cases and expanding scanner footprint may provide longer‑term upside not fully priced yet.
Background
Align Technology reported Q3 2026 results, beating earnings and revenue estimates but lowered its full‑year outlook, leading to a modest share decline.
Ticker impact
Q3 2026 earnings beat estimates but 2026 revenue outlook lowered, shares fell 0.7% after-hours.
downward pressure as investors price in reduced revenue outlook and lower ASP assumptions.
Guidance cut for 2026 revenue and Systems/Services segment signals slower growth; market already reacted with a modest post‑earnings decline.
Market effects
Dental and orthodontic device sector may see broader scrutiny of growth assumptions, especially for systems revenue.
International growth helped offset U.S. pressure, but foreign exchange headwinds remain a concern.
Align is a leading player in clear aligner market; guidance shift could influence peers like Straumann and Dentsply.
Counterpoint
Despite the guidance cut, the beat on earnings and strong cash position could support a short‑term bounce if the market overreacts.
Key entities
- companyAlign Technology, Inc.
Provider of Invisalign clear aligners and dental imaging systems.
